New diabetes clinical trial: Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Published on: October 23, 2025 at 11:00PM
Conditions: Obesity; Overweight
Interventions: Drug: Cagrilintide; Drug: Placebo
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/ISv3cil